Trademark applications and grants for Dcprime B V. Dcprime B V has 2 trademark applications. The latest application filed is for "DCONE"
Patent Application | Date |
---|---|
METHODS OF VACCINATION AND USE OF CD47 BLOCKADE 20220305100 - 17/692321 Manting; Erik Hans ;   et al. | 2022-09-29 |
METHODS OF TUMOR VACCINATION 20220249639 - 17/580919 Manting; Erik Hans ;   et al. | 2022-08-11 |
USE OF TUMOR-INDEPENDENT ANTIGENS IN IMMUNOTHERAPIES 20220168407 - 17/519101 Manting; Erik Hans ;   et al. | 2022-06-02 |
COMBINATION PRODUCT FOR USE IN TUMOR VACCINATION 20220023406 - 17/361462 MANTING; Erik Hans ;   et al. | 2022-01-27 |
USE OF LEUKEMIA-DERIVED CELLS IN OVARIAN CANCER VACCINES 20220023405 - 17/361477 Manting; Erik Hans ;   et al. | 2022-01-27 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "DCONE" 4137720 85263328 |
DCONE 2011-03-10 |
![]() "DCPRIME" 4137721 85263336 |
DCPRIME 2011-03-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.